Lobbying client

LINCOLN THERAPEUTICS

Biotechnology industry

Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$100,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2023 to 2024

Filings

9 filings, newest first.
Filing Filed by Amount
4th Quarter - Termination
4th Quarter 2024
MCALLISTER & QUINN, LLC $10,000 reported
3rd Quarter - Report
3rd Quarter 2024
MCALLISTER & QUINN, LLC $10,000 reported
2nd Quarter - Report
2nd Quarter 2024
MCALLISTER & QUINN, LLC $10,000 reported
1st Quarter - Report
1st Quarter 2024
MCALLISTER & QUINN, LLC $30,000 reported
4th Quarter - Report
4th Quarter 2023
MCALLISTER & QUINN, LLC — reported
3rd Quarter - Report
3rd Quarter 2023
MCALLISTER & QUINN, LLC — reported
2nd Quarter - Report
2nd Quarter 2023
MCALLISTER & QUINN, LLC $40,000 reported
1st Quarter - Report
1st Quarter 2023
MCALLISTER & QUINN, LLC — reported
Registration
1st Quarter 2023
MCALLISTER & QUINN, LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
MCALLISTER & QUINN, LLC 8 $100,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Budget/Appropriations BUD 9
Defense DEF 9
Health Issues HCR 9

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 4365 118th 9
S. 2584 118th 6
S. 4921 118th 6

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.